Paul A Volberding
Overview
Explore the profile of Paul A Volberding including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
3187
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Choi A, Li Y, Deeks S, Grunfeld C, Volberding P, Shlipak M
Circulation
. 2010 Jan;
121(5):651-8.
PMID: 20100969
Background: Cardiovascular disease (CVD) is now a leading cause of death in HIV-infected persons; however, risk markers for CVD are ill defined in this population. We examined the association between...
22.
Hammer S, Eron Jr J, Reiss P, Schooley R, Thompson M, Walmsley S, et al.
JAMA
. 2008 Aug;
300(5):555-70.
PMID: 18677028
Context: The availability of new antiretroviral drugs and formulations, including drugs in new classes, and recent data on treatment choices for antiretroviral-naive and -experienced patients warrant an update of the...
23.
Choi A, Rodriguez R, Bacchetti P, Volberding P, Havlir D, Bertenthal D, et al.
Clin Infect Dis
. 2008 Jan;
45(12):1633-9.
PMID: 18190326
Background: It is unknown whether chronic kidney disease (CKD) influences receipt of highly active antiretroviral therapy (HAART) among patients with the human immunodeficiency virus (HIV) and whether prescription practices contribute...
24.
Choi A, Rodriguez R, Bacchetti P, Bertenthal D, Volberding P, OHare A
J Am Soc Nephrol
. 2007 Oct;
18(11):2968-74.
PMID: 17942954
Few studies have compared the incidence of end-stage renal disease (ESRD) among individuals with the human immunodeficiency virus (HIV) and diabetes. We followed a national sample of 2,015,891 US veterans...
25.
Behler C, Vittinghoff E, Lin F, Chung R, Peters M, Robbins G, et al.
Clin Infect Dis
. 2007 Apr;
44(10):1375-83.
PMID: 17443478
Background: This study investigates whether dose modifications for adverse hematologic effects or the use of hematopoietic growth factors influenced the outcome of therapy for hepatitis C virus (HCV) infection in...
26.
Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society--USA panel
Hammer S, Saag M, Schechter M, Montaner J, Schooley R, Jacobsen D, et al.
Top HIV Med
. 2006 Oct;
14(3):827-43.
PMID: 17016878
Context: Guidelines for antiretroviral therapy are important for clinicians worldwide given the complexity of the field and the varied clinical situations in which these agents are used. The International AIDS...
27.
Hammer S, Saag M, Schechter M, Montaner J, Schooley R, Jacobsen D, et al.
JAMA
. 2006 Aug;
296(7):827-43.
PMID: 16905788
Context: Guidelines for antiretroviral therapy are important for clinicians worldwide given the complexity of the field and the varied clinical situations in which these agents are used. The International AIDS...
28.
29.
Michaels M, Kaufman C, Volberding P, Gupta P, Switzer W, Heneine W, et al.
Transplantation
. 2004 Dec;
78(11):1582-9.
PMID: 15591945
Background: Xenotransplantation offers a solution to the shortage of organ donors and may offer resistance to human-specific pathogens. Baboons are resistant to productive infection with HIV-1. A baboon bone-marrow transplant...
30.
Henry D, Volberding P, Leitz G
J Acquir Immune Defic Syndr
. 2004 Sep;
37(2):1221-7.
PMID: 15385728
Despite the availability of highly active antiretroviral therapy and the resulting reduction in severe anemia associated with HIV infection, epoetin alfa has continued to play an important role in the...